Key result
Prehypertensive renin inhibition with aliskiren reduced mean arterial pressure and cardiac hypertrophy in adult spontaneously hypertensive rats, associated with higher cardiac capillary density.
Why the study?
Does aliskiren improve capillary density and modulate angiogenesis in spontaneously hypertensive rats?
Does aliskiren improve capillary density and modulate angiogenesis in spontaneously hypertensive rats?
Renin inhibition modulates anti-angiogenesis signaling independently of blood pressure, promoting higher capillary density in spontaneously hypertensive rats.
May inform angiogenesis research in hypertension models; does not support clinical use of prehypertensive aliskiren.
BACKGROUND: Spontaneously hypertensive rats (SHRs) are characterized by capillary rarefaction, which may contribute to blood pressure elevation. We hypothesized that capillary rarefaction involves a suppressed angiogenesis; renin inhibition influences anti-angiogenesis homeostasis by acting on angiopoietins; transient renin blockade reduces anti-angiogenesis thereby ameliorating long-lasting blood pressure and cardiac hypertrophy in SHRs. METHODS: First, serum angiopoietin-1 and angiopoietin-2 were measured in 2-month old normotensive Wistar-Kyoto rats (WKYs) and SHRs after renin inhibition (aliskiren: 1 and 10 mg/kg per day) or placebo. Second, 4-week old SHRs were prehypertensively treated with aliskiren (1 and 10 mg/kg per day) or placebo for 4 weeks. After 4 weeks of 'drug holiday' 12-week old SHRs were given L-nitro-arginine methyl ester (L-NAME) (25 mg/kg per day) for a 4-week interval to promote capillary rarefaction. Thereafter, mean arterial pressure (MAP), cardiac remodeling, capillary density, pAkt/Akt as marker for cellular survival, pro-angiogenic genes and systemic angiopoietins were investigated. RESULTS: Baseline angiopoietin levels were similar between WKYs and SHRs. Renin inhibition increased angiopoietin-1 in SHR and reduced angiopoietin-2 in both WKY and SHR blood pressure independently. Prehypertensive renin inhibition reduced MAP and cardiac hypertrophy in adult SHRs. This was associated with higher cardiac capillary density, pAkt/Akt, pro-angiogenic expression pattern and serum angiopoietin-1, whereas angiopoietin-2 was lower as compared to vehicle-pretreated SHRs. These results were independent of prehypertensive blood pressure lowering by aliskiren. CONCLUSION: We conclude that renin inhibition modulates anti-angiogenesis signaling independently of blood pressure by increasing angiopoietin-1/angiopoietin-2 ratio. This promotes in SHR stabilization of endothelial cells, favors pro-angiogenic action and consequently results in higher capillary density.
No takes yet. Share an insight, caveat, or question.
Rusai et al. (2010) studied Hypertension. Renin inhibition (aliskiren) vs. Placebo was evaluated on Mean arterial pressure, cardiac remodeling, capillary density, pAkt/Akt, pro-angiogenic genes and systemic angiopoietins. Prehypertensive renin inhibition with aliskiren reduced mean arterial pressure and cardiac hypertrophy in adult spontaneously hypertensive rats, associated with higher cardiac capillary density.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: